Nutritional biotechnology for human metabolic health, utilizing plant-based smart microgels to deliver satiety and therapeutic compounds.
Year: 2025
Type: article
Abstract: Hydra-Cure Pro: Complete Technical Description Title: Hydra-Cure Pro - Smart Microgel-Based Nutritional Supplement for Metabolic Health, Satiety Control, and Liver Regeneration 1. Technical Field The present invention relates generally to the field of nutritional biotechnology and functional foods, specifically to a novel plant-based supplement system incorporating smart microgel technology for the management of metabolic health. More particularly, the invention provides a multi-functional composition comprising expandable dietary fibers forming a smart microgel matrix in the stomach to induce prolonged satiety, combined with controlled-release microcapsules delivering therapeutic bioactive compounds to the intestines for supporting liver regeneration, glycemic control, and lipid profile optimization. 2. Background of the Invention The global epidemic of metabolic disorders including obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD) presents unprecedented challenges to healthcare systems worldwide. Current therapeutic approaches include pharmaceutical interventions with significant side effects, surgical procedures with associated risks, and dietary modifications that often fail due to poor patient adherence and the complex interplay of hunger signals, nutrient absorption, and metabolic regulation. Conventional nutritional supplements face several limitations: · Poor bioavailability of many beneficial compounds due to degradation in the gastrointestinal tract · Rapid gastric emptying leading to insufficient satiety and frequent hunger · Digestive discomfort from high-fiber formulations · Incompatibility with diabetic, gluten-sensitive, or allergen-restricted diets · Single-target approaches that fail to address the multifactorial nature of metabolic diseases There exists a pressing need for a comprehensive nutritional intervention that simultaneously addresses multiple aspects of metabolic health while ensuring optimal delivery of therapeutic compounds and maintaining excellent tolerability across diverse populations. 3. Summary of the Invention Hydra-Cure Pro is a revolutionary plant-based nutritional supplement system that combines smart microgel technology with targeted therapeutic delivery to address the complex pathophysiology of metabolic disorders. The formulation is available in powder or capsule form and operates through a dual-mechanism approach: immediate satiety induction via stomach expansion, followed by controlled release of therapeutic compounds in the intestines. Key innovations of the invention include: · Smart microgel matrix comprising plant-derived fibers that undergo rapid hydration and expansion in the gastric environment, creating prolonged physical satiety and reducing caloric intake · Controlled-release microencapsulation system protecting sensitive bioactive compounds during gastric transit and delivering them precisely to the intestinal absorption sites · Multi-target therapeutic nutrient blend simultaneously addressing liver health (regeneration and detoxification), glycemic control (insulin sensitivity and glucose metabolism), and lipid profiles (cholesterol and triglyceride management) · Adaptive delivery mechanism responsive to individual digestive pH profiles, ensuring consistent therapeutic effects across diverse populations · Completely plant-based, allergen-free formulation suitable for diabetics, individuals with food sensitivities, and populations with religious or ethical dietary restrictions · Enhanced bioavailability through phytosome technology and nanoparticle encapsulation of key compounds 4. Detailed Description of the Invention 4.1 Overall System Architecture The Hydra-Cure Pro system comprises two integrated but functionally distinct components: 1. Smart Microgel Matrix Component: Rapidly hydrating dietary fibers that form a physical gel network in the stomach 2. Therapeutic Nutrient Microcapsules: Protected delivery vehicles containing bioactive compounds, released in the intestines These components can be formulated together in a single powder blend or separated into dual-compartment capsules depending on the desired application format. 4.2 Component 1: Smart Microgel Matrix Composition and Materials: The smart microgel matrix consists of a synergistic blend of plant-derived, water-soluble and partially soluble fibers selected for their rapid hydration kinetics, gel-forming capacity, and physiological compatibility: · Primary Gelling Agents (60-75% of fiber blend): · Guar Gum (Cyamopsis tetragonoloba): Galactomannan polysaccharide with exceptional water-holding capacity (up to 100 times its weight), forming viscous gels at low concentrations (1-2%). Modified with partial hydrolysis to reduce viscosity while maintaining gel strength for optimal palatability. · Apple Pectin (Malus domestica): High-methoxyl pectin with rapid gelation in acidic gastric environment, providing additional structure to the gel network and contributing prebiotic fibers. · Fungal Chitosan (Aspergillus niger-derived): Beta-(1,4)-linked D-glucosamine polymer with unique mucoadhesive properties, extending gastric retention time and providing additional lipid-binding capacity. · Secondary Structuring Agents (15-25% of fiber blend): · Konjac Glucomannan (Amorphophallus konjac): High molecular weight polysaccharide forming extremely viscous solutions, synergistic with guar gum for enhanced gel strength. · Alginates (Brown seaweed-derived): Sodium alginate that forms calcium-mediated gels in the stomach, providing additional structural integrity to the microgel matrix. · Functional Enhancers (5-10%): · Inulin (Chicory root-derived): Fructan-type prebiotic fiber supporting gut microbiome health while contributing minimal viscosity. · Beta-glucans (Oat or barley-derived): Soluble fibers with demonstrated cholesterol-lowering effects, integrated into the gel matrix. Physical Properties and Mechanism: Upon ingestion and exposure to gastric fluid (pH 1.5-3.5, 37°C), the fiber blend undergoes rapid hydration: · Hydration Kinetics: 80% of maximum water uptake achieved within 15-20 minutes · Expansion Ratio: 30-50 times original dry volume, forming a cohesive, viscoelastic gel · Gel Strength: Storage modulus (G') of 50-200 Pa, sufficient to maintain structural integrity against gastric peristalsis · Gastric Retention: Extended residence time of 2-4 hours compared to 30-60 minutes for liquid meals Satiety Mechanism: The expanded gel occupies significant gastric volume, activating stretch receptors in the stomach wall and triggering vagal afferent signals to the hypothalamus. This produces several physiological effects: · Increased secretion of satiety hormones (PYY, GLP-1, CCK) · Delayed gastric emptying of co-ingested nutrients · Reduced ghrelin (hunger hormone) secretion · Physical sensation of fullness lasting 3-5 hours post-consumption 4.3 Component 2: Therapeutic Nutrient Microcapsules The therapeutic nutrient blend is protected within a multi-layered microencapsulation system designed to withstand gastric conditions and release bioactive compounds precisely in the intestinal environment. Microencapsulation Technology: · Core-Shell Structure: · Core Matrix: Lipid-based (medium-chain triglycerides) or protein-based (rice protein isolate) carrier containing dissolved or suspended bioactive compounds · Inner Shell: Alginate-calcium gel (100-200 μm thickness) providing structural integrity and moisture barrier · Outer Shell: pH-responsive polymer coating (Eudraguard® or cellulose acetate phthalate) that remains intact at gastric pH (1.5-3.5) and dissolves at intestinal pH (6.5-7.5) · Microcapsule Specifications: · Size range: 100-500 μm diameter for powder formulations; 1-2 mm for capsule formulations · Encapsulation efficiency: >85% for all bioactive compounds · Gastric stability: <10% release after 2 hours in simulated gastric fluid · Intestinal release: >90% release within 3 hours in simulated intestinal fluid Therapeutic Nutrient Blend Composition: The bioactive compounds are selected for their synergistic effects on liver health, glycemic control, and lipid metabolism: 4.3.1 Liver Health and Regeneration Complex · Silymarin Phytosome (Silybum marianum): · Composition: Standardized to 80% silymarin complex complexed with phosphatidylcholine (1:1 or 1:2 molar ratio) · Dose range: 100-300 mg per serving · Mechanism: Antioxidant (free radical scavenging), anti-inflammatory (NF-κB inhibition), antifibrotic (TGF-β suppression), and hepatocyte regeneration promotion through stimulation of ribosomal RNA synthesis · Bioavailability enhancement: Phytosome technology increases absorption 5-10 fold compared to standard silymarin · Phytosomal Curcumin (Curcuma longa): · Composition: Standardized to 95% curcuminoids complexed with phosphatidylcholine · Dose range: 100-400 mg per serving · Mechanism: Potent anti-inflammatory (COX-2, LOX inhibition), antioxidant, and hepatoprotective effects; reduces hepatic steatosis and inflammation in NAFLD · Bioavailability: Phytosome formulation provides 20-30 fold higher absorption versus unformulated curcumin · N-Acetylcysteine (NAC): · Dose range: 200-600 mg per serving · Mechanism: Precursor to glutathione (master antioxidant), supports phase II detoxification pathways, reduces oxidative stress in hepatocytes · Alpha-Lipoic Acid: · Dose range: 100-300 mg per serving · Mechanism: Mitochondrial antioxidant, improves insulin sensitivity, reduces hepatic oxidative stress 4.3.2 Glycemic Control Complex · Berberine HCl (Berberis aristata): · Composition: Standardized to 97% berberine alkaloids · Dose range: 200-500 mg per serving · Mechanism: AMPK activation (same pathway as metformin), impr
Author: Sajedi, Asal
Language: English
Subfield: Molecular Medicine
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7083589387
FWCI:
Cites:
Cited by:
Related to: